公开(公告)号：EP2116533A4

公开(公告)日：2012-01-25

申请号：EP08721434

申请日：2008-03-06

申请人： KYORIN SEIYAKU KK ,  TEIJIN PHARMA LTD

发明人： FUKUDA YASUMICHI ,  ASAHINA YOSHIKAZU ,  TAKADOI MASANORI ,  OHATA KOHEI ,  IDE TOMOHIRO ,  KOBAYASHI FUMIYOSHI ,  KOBAYASHI SHINJI ,  KOMATSU KANJI ,  YAMAMOTO MASANORI

IPC分类号： C07D213/75 ,  A61K31/415 ,  A61K31/421 ,  A61K31/426 ,  A61K31/433 ,  A61K31/437 ,  A61K31/4965 ,  A61P3/04 ,  A61P3/10 ,  A61P43/00 ,  C07D231/38 ,  C07D241/20 ,  C07D263/14 ,  C07D277/20 ,  C07D277/46 ,  C07D277/56 ,  C07D285/12

CPC分类号： C07D277/46 ,  C07C317/44 ,  C07C2601/02 ,  C07C2601/08 ,  C07D213/75 ,  C07D231/40 ,  C07D241/20 ,  C07D261/14 ,  C07D277/82 ,  C07D285/08 ,  C07D405/04 ,  C07D405/06 ,  C07D405/12 ,  C07D417/04 ,  C07D498/04 ,  C07D513/04

公开(公告)号：EP2116535A4

公开(公告)日：2013-05-29

申请号：EP07851044

申请日：2007-12-21

申请人： KYORIN SEIYAKU KK ,  TEIJIN PHARMA LTD

发明人： FUKUDA YASUMICHI ,  ASAHINA YOSHIKAZU ,  NAKAMURA AYAKO ,  FUJITA KENJI ,  IDE TOMOHIRO ,  KOBAYASHI FUMIYOSHI ,  KOBAYASHI SHINJI ,  KOMATSU KANJI ,  YAMAMOTO MASANORI

IPC分类号： C07D213/75 ,  A61K31/415 ,  A61K31/421 ,  A61K31/426 ,  A61K31/433 ,  A61K31/437 ,  A61K31/4965 ,  A61P3/04 ,  A61P3/10 ,  A61P43/00 ,  C07D231/38 ,  C07D241/20 ,  C07D263/14 ,  C07D277/20 ,  C07D277/46 ,  C07D277/56 ,  C07D285/12

CPC分类号： C07C317/44 ,  C07C2601/08 ,  C07D213/75 ,  C07D213/80 ,  C07D215/38 ,  C07D217/22 ,  C07D231/40 ,  C07D237/20 ,  C07D239/42 ,  C07D241/20 ,  C07D241/28 ,  C07D241/44 ,  C07D261/14 ,  C07D263/48 ,  C07D275/02 ,  C07D277/20 ,  C07D277/46 ,  C07D277/82 ,  C07D285/08 ,  C07D417/04 ,  C07D471/04 ,  C07D487/04 ,  C07D498/04 ,  C07D513/04

公开(公告)号：EP1690932A4

公开(公告)日：2008-03-05

申请号：EP04792995

申请日：2004-10-20

申请人： TEIJIN PHARMA LTD ,  KOMORI TOSHIHISA

发明人： KOMORI TOSHIHISA ,  KANATANI NAOKO ,  YOSHIDA CAROLINA ANDREA ,  ZANMA AKIRA ,  KOBAYASHI SHINJI ,  YAMANA KEI

IPC分类号： C12N15/00 ,  A61K38/00 ,  A61K38/17 ,  A61P19/00 ,  C07K14/46 ,  C07K14/47 ,  C12N5/10 ,  C12Q1/68

CPC分类号： C07K14/47 ,  A61K38/00 ,  C12Q2600/158

摘要： It is intended to provide a method of acquiring a gene inhibiting cartilage differentiation which comprises forcibly expressing a transcriptional factor in a cell lacking the transcriptional factor (preferably forcibly expressing Runx2/Cbfa1 in a chondrocyte lacking Runx2/Cbfa1), and acquiring a gene the expression of which is thus induced by the DNA chip method, the subtraction method or the like; and a chondrocyte lacking Runx2/Cbfa1 which is needed in performing the above method. It is also intended to provide a polynucleotide obtained by the above method; a polypeptide encoded by the polynucleotide; an antibody against the polypeptide; a recombinant vector containing the polynucleotide; a transformant having the recombinant DNA vector; a cell expressing the polypeptide; a transgenic animal having the polynucleotide; a model animal of bone and/or joint diseases (preferably arthritis derformans); a method of screening a remedy and/or a preventive for bone and/or joint diseases (preferably arthritis derformans) by using the above susbtance(s); a candidate compound for a remedy and/or a preventive selected by this method; and a medicinal composition and a diagnostic method for bone and/or joint diseases (preferably arthritis derformans).